[Treatment of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (author's transl)].
D000293:Adolescent; D000328:Adult; D001120:Arginine / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D002648:Child; D002986:Clinical Trials as Topic; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004231:Diuresis / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008239:Lysine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D011674:Pulse / Q000187:drug effects; D014667:Vasopressins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
D014667:Vasopressins; D001120:Arginine; D008239:Lysine
Behandlung des Diabetes insipidus mit 1-Desamino-8-D-Arginin-Vasopressin